Research in biogerontology has largely focused on the complex relationship between mitochondrial dysfunction and biological aging. In particular, the mitochondrial free radical theory of aging (MFRTA) has been well accepted. However, this theory has been challenged by recent studies showing minimal increases in reactive oxygen species (ROS) as not entirely deleterious in nature, and even beneficial under the appropriate cellular circumstances. To assess these significant and nonintuitive observations in the context of a functional system, we have taken an in silico approach to expand the focus of the MFRTA by including other key mitochondrial stress response pathways, as they have been observed in the nematode Caenorhabditis elegans. These include the mitochondrial unfolded protein response (UPRmt ), mitochondrial biogenesis and autophagy dynamics, the relevant DAF-16 and SKN-1 axes, and NAD+ -dependent deacetylase activities. To integrate these pathways, we have developed a multilevel hybrid-modeling paradigm, containing agent-based elements among stochastic system-dynamics environments of logically derived ordinary differential equations, to simulate aging mitochondrial phenotypes within a population of energetically demanding cells. The simulation experiments resulted in accurate predictions of physiological parameters over time that accompany normal aging, such as the declines in both NAD+ and ATP and an increase in ROS. Additionally, the in silico system was virtually perturbed using a variety of pharmacological (e.g., rapamycin, pterostilbene, paraquat) and genetic (e.g., skn-1, daf-16, sod-2) schemes to quantitate the temporal alterations of specific mechanistic targets, supporting insights into molecular determinants of aging as well as cytoprotective agents that may improve neurological or muscular healthspan.
Research in biogerontology has largely focused on the complex relationship between mitochondrial dysfunction and biological aging. In particular, the mitochondrial free radical theory of aging (MFRTA) has been well accepted. However, this theory has been challenged by recent studies showing minimal increases in reactive oxygen species (ROS) as not entirely deleterious in nature, and even beneficial under the appropriate cellular circumstances. To assess these significant and nonintuitive observations in the context of a functional system, we have taken an in silico approach to expand the focus of the MFRTA by including other key mitochondrial stress response pathways, as they have been observed in the nematode Caenorhabditis elegans. These include the mitochondrial unfolded protein response (UPRmt ), mitochondrial biogenesis and autophagy dynamics, the relevant DAF-16 and SKN-1 axes, and NAD+ -dependent deacetylase activities. To integrate these pathways, we have developed a multilevel hybrid-modeling paradigm, containing agent-based elements among stochastic system-dynamics environments of logically derived ordinary differential equations, to simulate aging mitochondrial phenotypes within a population of energetically demanding cells. The simulation experiments resulted in accurate predictions of physiological parameters over time that accompany normal aging, such as the declines in both NAD+ and ATP and an increase in ROS. Additionally, the in silico system was virtually perturbed using a variety of pharmacological (e.g., rapamycin, pterostilbene, paraquat) and genetic (e.g., skn-1, daf-16, sod-2) schemes to quantitate the temporal alterations of specific mechanistic targets, supporting insights into molecular determinants of aging as well as cytoprotective agents that may improve neurological or muscular healthspan.
Loss of mitochondrial function is one of the most well‐established characteristics of aging cells. Because of this, many researchers speculate that the decline in mitochondrial function is not only a complex consequence of biological aging, but may provide the earliest trigger in time‐dependent cellular senescence and degeneration (Van Raamsdonk & Hekimi, 2010; Wang & Hekimi, 2015). The first viable theory explaining this relationship is the mitochondrial free radical theory of aging (MFRTA), which suggests that increasing levels of mitochondrial ROS (mtROS) produced by cellular respiration and the electron transport chain (ETC) are responsible for age‐dependent damage, especially toward copies of mitochondrial DNA (mtDNA) (Harman, 1956; Balaban et al., 2005). According to this theory, when mtDNA and matrix proteins exist in an oxidatively damaged state, ETC function may be reduced and proteostasis may be lost, resulting in a deleterious cyclic propagation of mtROS generation and a decrease in cellular respiratory function. The MFRTA has been adapted and strengthened over the years to address many of the complexities and nuances associated with mitochondrial dysfunction in aging cells (Hekimi et al., 2011; Ziegler et al., 2015). For example, more recent findings suggest that the accumulation of loss‐of‐function mutations is not entirely mtROS‐dependent (Kujoth et al., 2005; Kennedy et al., 2013), and have demonstrated that minimal increases in endogenous mtROS may be fairly benign or, controversially, cytoprotective in nature (Yang & Hekimi, 2010; Gruber et al., 2011). These contrasting data warrant further investigation of this theory as a pertinent and highly multifaceted system in aging organisms.One additional dimension that adds much value to the MFRTA involves the general response pathway by which the mitochondrion adapts to stress: the mitochondrial unfolded protein response (UPRmt). This response is conserved across an array of species, and presumably all eukaryotes, and may largely account for the interplay that dulls the downstream oxidative effects of mitochondrial damage during aging (Schulz & Haynes, 2015). The UPRmt is activated directly or indirectly by a variety of stress signals originating from the ETC and the intramitochondrial environment (Yoneda et al., 2004; Nargund et al., 2012; Pulliam et al., 2014). This activated response has been extensively studied within the nematode Caenorhabditis elegans, where the UPRmt is mediated by nuclear import of an important protein known as activating transcription factor associated with stress‐1 (ATFS‐1) (Nargund et al., 2012). This transcription factor is regulated in such a way that allows the cell to globally monitor mitochondrial stress and damage, and it effectively produces a widely protective transcriptional response when present in the nucleus. Among the several hundred transcripts upregulated by nuclear ATFS‐1 accumulation are those encoding for important mitochondrial proteins necessary for antioxidant defense and proteostasis, for example, sod‐2/3, hsp‐60, hsp‐70, ymel‐1, and timm‐23 (Nargund et al., 2012; Mouchiroud et al., 2013). Additionally, this response negatively regulates the nuclear and mitochondrial expression of oxidative phosphorylation (OXPHOS) subunits to avoid the accumulation of superfluous proteins when mitochondria are already experiencing severe metabolic stress (Nargund et al., 2015). All of these functional changes promote mitochondrial health, which may in turn allow cells to live longer at a heightened state of performance.Although widely beneficial for proteostasis and respiratory maintenance within cells, the UPRmt has also been noted as a process that can sustain damage within the mitochondrial genome (Lin et al., 2016). It has been suggested that the UPRmt can be overprotective by sustaining the numbers of both functional and severely defective mitochondria within a given cell, although the mechanism by which this occurs is far from clear. The activation of this stress response may allow for high respiratory function for the majority of a lifespan, but once enough mtDNA copies hold deletions or mutations within their sequences, it is possible that the balance may shift toward a deleterious cellular mechanism caused in part by sustained UPRmt activation. This complete relationship has yet to be fully investigated.Mitochondrial autophagy, or mitophagy, is another process that appears to play a critical role in biological aging. Poor regulation of this process allows for the accumulation of aberrant mitochondrial content, which has been postulated as a driving force for deleterious senescence states, particularly for age‐associated neurodegenerative diseases such as dementia, Alzheimer's disease (AD), and Parkinson's disease (PD) (Palikaras & Tavernarakis, 2012; Menzies et al., 2015). Drastic manipulation of mitochondrial biogenesis and mitophagy flux in C. elegans stress models has been shown to cause decreases in ATP production, increased oxidative burdens, and ultimately shortened lifespans (Palikaras et al., 2015), demonstrating how important it is for these processes to be tightly regulated to allow for healthy aging. These regulatory dynamics are also well conserved across a variety of animal species.The causal role of dysfunctional mitochondrial dynamics in the process of biological aging remains fairly nebulous. All the aforementioned mitochondrial processes have been hypothesized as important factors that determine the rate and results of biological aging, yet it has been rather difficult to investigate all of these processes simultaneously and to quantitate their ultimate effects when compounded. Computational models have been able to provide an additional means to investigate such complex systems and have gained a great deal of interest specifically for the field of biogerontology (Mooney et al., 2016). The aim of using such an approach is to not only gain insights about the molecular determinants of tissue aging but to also gain quantitative insights about how such determinants can be targeted therapeutically.Here we emphasize that the degenerative aging response is not a result of a single concrete cellular pathway, but is dependent upon specific magnitudes of multiple key mitochondrial pathways that allow for cellular senescence states and pathological phenotypes. To illuminate these theories in a more nuanced manner, we took an approach that highlights existing data and integrates them into a systemic computational modeling approach. Our theoretical model addresses vital cellular components and time‐dependent macromolecule quantities that account for biological aging within the model organism C. elegans – including bioenergetic functions of the mitochondrion, fundamental observations of the MFRTA, known elements of the UPRmt, and mitophagy‐dependent quality control processes (Fig. 1A). This framework was modeled using multimethod simulation software, allowing us to employ system‐dynamics elements (e.g., stocks and flows) as well as agent‐based functions (i.e., those that define discrete events, stochasticity, and seemingly autonomous cellular behavior). Additionally, our in silico approach included a hierarchical modeling scheme to control mitochondrial‐level dynamics within a population of energetically demanding cells, allowing us to generate predictive and probabilistic data at the single‐cell level (Fig. 1B). This theoretical model aims to provide a better understanding of all the significant cellular components that may account for mitochondrial function and dysfunction in biological aging with a quantitative backing that may aid in making experimental predictions for age‐related diseases, toxicological endpoints, and potential pharmacological or dietary anti‐aging therapies.
Figure 1
The integrated aging mechanism of interest and computational simulation approach. (A) Respiratory machinery produces both ATP and superoxide, which elicits different types of intramitochondrial damage (noted above as changes in mitochondrial stress states) and activation of various cellular stress response pathways. Such pathways focused on here are the UPR
mt, dictated by nuclear accumulation of transcription factor ATFS‐1, mitochondrial biogenesis and selective mitophagy, and activation of transcription factors DAF‐16 and SKN‐1. This integrated mechanism was also virtually probed by pharmacological agents that modulate either mitophagy, oxidative metabolism, or antioxidant defenses. Rapamycin induces mitophagy, bafilomycin hinders mitophagy, paraquat causes additional superoxide production and can activate the UPR
mt, and pterostilbene directly and indirectly boosts cellular antioxidant capacity. UPR
mt, mitochondrial unfolded protein response; NLS, nuclear localization signal; MTS, mitochondria targeting sequence; Rapa, rapamycin; Baf, bafilomycin; PQ, paraquat; PT, pterostilbene. (B) The simulation approach has been characterized as having two dimensions of complexity integrated over time: hierarchical or leveled complexity, and scalar complexity (i.e., magnitude of segments). These constructs were employed to produce large scale predictive datasets over time on the single‐cell level (denoted by black dots) which were distilled down into tissue‐level averages (denoted by red line).
The integrated aging mechanism of interest and computational simulation approach. (A) Respiratory machinery produces both ATP and superoxide, which elicits different types of intramitochondrial damage (noted above as changes in mitochondrial stress states) and activation of various cellular stress response pathways. Such pathways focused on here are the UPR
mt, dictated by nuclear accumulation of transcription factor ATFS‐1, mitochondrial biogenesis and selective mitophagy, and activation of transcription factors DAF‐16 and SKN‐1. This integrated mechanism was also virtually probed by pharmacological agents that modulate either mitophagy, oxidative metabolism, or antioxidant defenses. Rapamycin induces mitophagy, bafilomycin hinders mitophagy, paraquat causes additional superoxide production and can activate the UPR
mt, and pterostilbene directly and indirectly boosts cellular antioxidant capacity. UPR
mt, mitochondrial unfolded protein response; NLS, nuclear localization signal; MTS, mitochondria targeting sequence; Rapa, rapamycin; Baf, bafilomycin; PQ, paraquat; PT, pterostilbene. (B) The simulation approach has been characterized as having two dimensions of complexity integrated over time: hierarchical or leveled complexity, and scalar complexity (i.e., magnitude of segments). These constructs were employed to produce large scale predictive datasets over time on the single‐cell level (denoted by black dots) which were distilled down into tissue‐level averages (denoted by red line).
Results
Multimethod simulation development
The pathways of interest for the model were selected based on their broadly protective or damaging mitochondrial effects and their conserved significance toward the aging process observed over recent years. Such pathways were then compiled into a fully integrated system of mitochondrial health (Fig. 1A). This network was constructed within our simulation interface predominately by using deterministic frameworks to model both intramitochondrial reactions (Fig. S1A) and cytosolic and nuclear activities (Fig. S2A). To extend our investigation beyond traditional single‐method deterministic modeling, we overlaid an agent‐based framework for multiple events that have classically been difficult to model with differential equations and flow rates. This framework was primarily added to observe the aging kinetics of mitochondrial stress‐state phenotyping (Fig. S1B) and mito‐compromised cell states that eventually result in apoptotic cell death (Fig. S2B). Such agent‐based events occur discretely within the model and are bound by conditions or stochastic damage‐dependent frequencies. It is important to note that this multimethod framework was built expansively and hierarchically (Fig. 1B), where the model simulated a population of cells each with its own functioning reaction network and with its own population of mitochondria that were constantly undergoing biogenesis, stress‐dependent mitophagy, and mitochondrial recycling. Each mitochondrion within a cell's population also contained its own stochastic reaction network that controlled not only its own phenotypic stress state, but the state of the cell and thus the states of other mitochondria.To fill this network with realistic parameters and relevant reaction schemes for the aging nematode, we gathered a vast set of information from the literature to determine: mitochondria counts and mtDNA counts (Table S1 and Box S1); mitochondrion‐level system‐dynamics and discrete‐event computational methods for oxidative metabolism, proteostasis, and heteroplasmic mtDNA analysis (Table S2 and Box S2); damage‐dependent agent‐based progression and recovery through mitochondrial stress states that lead to mitophagy (Box S3); cell‐level system‐dynamics computational methods surrounding the UPRmt and mitochondrial protein import (Table S3 and Box S4); and agent‐based principles that govern stress‐dependent cellular degeneration (Box S5). These modeled reaction schemes consist of logically derived ordinary differential equations (ODEs) or discrete‐event statements, which simulate reactions such as ATP production, superoxide production, peroxide formation, mtROS elimination, baseline protein production and transcriptionally activated protein synthesis, protein import, and damage to and clonal expansion of mtDNA copies. The parameters used to fill these reaction schemes were (i) directly obtained and/or converted from previous models, (ii) assumed based on qualitative evidence, or (iii) individually optimized over 5000 parameter iterations to reach appropriate curves for the separate model components. All values and corresponding sources are reported as such in the Supporting Information.We have drawn upon previous deterministic computational models of aging, including a deterministic mathematical analysis of superoxide production and disposition to complement C. elegans data (Gruber et al., 2011) and a compartmentalized dynamic model of oxidative metabolism carried out to predict endpoints seen in PD development (Cloutier & Wellstead, 2012). We have also gained insights from a sophisticated stochastic modeling analysis of damaged mtDNA in aging mitochondria (Tam et al., 2015), where an OXPHOS defect threshold between 60% and 90% determined a deleterious senescence state with poor mitochondrial quality control. We built upon these original constructs and greatly expanded the focus to create a more complete view of the conserved cellular mechanisms implicated in biological aging. In doing so, we made a variety of assumptions and simplifications in our theoretical model to preserve the significance of the pathways involved and to arrive at a network that is mathematically logical. Importantly, the simulation assumes an isothermal environment (20 °C) for the duration of each virtual experiment, as C. elegans are poikilotherms and thus cannot properly adapt to drastic changes in temperature. Additional simplifications involve the condensed inclusion of conserved transcription factors DAF‐16 (FOXO family C. elegans ortholog) and SKN‐1 (orthologous to mammalianNRF family proteins), both of which have had profound implications in regulating longevity. When activated, DAF‐16 and SKN‐1 are largely responsible for mediating metabolic signals and antioxidant activities, and they have also been closely linked to the UPRmt and mitophagy regulation (Park et al., 2009; Robida‐Stubbs et al., 2012; Mouchiroud et al., 2013; Palikaras et al., 2015). As the focus of this study is on mitochondrial function, these two transcription factors were explicitly embedded into the biological network to account mainly for the responses they elicit that significantly affect mitochondrial populations.To make functional use of our cellular simulation, we have designed equations to capture key endpoints that have been observed quantitatively or qualitatively in aging C. elegans. Said endpoints include relative NAD+ levels, oxygen consumption rates, ATP content, tissue‐level and single‐cell mtROS content, tissue‐level and single‐cell mtDNA/∆mtDNA copy numbers, mitochondrial stress states and mitophagy flux, mitochondria count, and age‐dependent cellular senescence states and cell death (Box S6). The time frame simulated was between 0 and 30 000 min, to assess a window of time surrounding the average nematode lifespan of 2–3 weeks.
Model performance and predictions for spontaneous functional declines
Cellular characteristics of aging are all directly associated with a general decrease in cellular performance and are predominately regulated by OXPHOS functionality and overall mitochondrial health – especially in tissues with high energy demands. These functional declines ultimately manifest as decreases in ATP production, which have been ascribed to a variety of factors but the most significant of which include faulty matrix proteins and decreased metabolic substrate availabilities (Imai & Guarente, 2014). As a key substrate needed for respiration and other metabolic functions, NAD+ has been closely studied as an important molecule in healthy aging and has shown to decline in whole organisms over time (Mouchiroud et al., 2013; Fang et al., 2014). As such, nucleotide dynamics have been incorporated into our simulation constructs as a critical mediator of bioenergetic function, and we have with reasonable uncertainty predicted the relative declines that have been observed in C. elegans experimentally (Fig. 2A). As an additional measurable parameter of mitochondrial health and bioenergetic efficiency, oxygen consumption rates were calculated by the simulation over the course of a nematode lifespan and were compared to experimental datasets of the same decline generated by Gruber et al. (2011), Moroz et al. (2014), and Mouchiroud et al. (2013) (Fig. 2B). Some experimental oxygen consumption values were converted to units of pmol min−1 per worm assuming an average protein mass per worm of 0.681 ± 0.002 μg (Table S1). As an ultimate output of the bioenergetic simulation component, cellular ATP levels were assessed and compared to values quantified in whole worms by Gruber et al. (2011) (Fig. 2C). The concentration values generated by Gruber et al. (2011) have been converted to units of mm assuming an average worm body volume of 3.5 × 10−9 L (Table S1). In the model, a sharp decline in tissue ATP presents itself after NAD+ levels have begun to decline (around 7500 min). ATP reduction then saturates around 20 000 min and becomes erratic toward the end of life due to the battery of activated stress responses in age‐compromised cells.
Figure 2
Experimental and predictive biomarkers of bioenergetic function for normal and pharmacologically altered aging in Caenorhabditis elegans. (A) Predicted NAD
+ values over time relative to initial time point values, compared to C. elegans experimental data from Fang et al. (2014) and Mouchiroud et al. (2013). (B) Simulated oxygen consumption decline with age, compared to C. elegans experimental data from Mouchiroud et al. (2013), Gruber et al. (2011), and Moroz et al. (2014). Some experimental oxygen consumption values were converted assuming an average protein mass per worm of 0.681 ± 0.002 μg. (C) Simulation ATP data for normal aging, compared to ATP levels shown experimentally in aging C. elegans by Gruber et al. (2011). Experimental ATP values were converted assuming an average worm body volume of 3.5 × 10−9 L. (D) Simulation ATP data were collected for the duration of natural aging as well as a variety of dosing schemes, including those that increased ATP production (rapamycin, pterostilbene, low‐dose paraquat) and those that decreased ATP production (bafilomycin, high‐dose paraquat).
Experimental and predictive biomarkers of bioenergetic function for normal and pharmacologically altered aging in Caenorhabditis elegans. (A) Predicted NAD
+ values over time relative to initial time point values, compared to C. elegans experimental data from Fang et al. (2014) and Mouchiroud et al. (2013). (B) Simulated oxygen consumption decline with age, compared to C. elegans experimental data from Mouchiroud et al. (2013), Gruber et al. (2011), and Moroz et al. (2014). Some experimental oxygen consumption values were converted assuming an average protein mass per worm of 0.681 ± 0.002 μg. (C) Simulation ATP data for normal aging, compared to ATP levels shown experimentally in aging C. elegans by Gruber et al. (2011). Experimental ATP values were converted assuming an average worm body volume of 3.5 × 10−9 L. (D) Simulation ATP data were collected for the duration of natural aging as well as a variety of dosing schemes, including those that increased ATP production (rapamycin, pterostilbene, low‐dose paraquat) and those that decreased ATP production (bafilomycin, high‐dose paraquat).Because of the hierarchical modeling scheme employed here, we were able to analyze markers of aging both at the tissue level and in single cells. Specifically, we produced quantitative predictions of single‐cell mtROS and heteroplasmic mtDNA content. The model was also designed to phenotypically categorize each individual mitochondrion based on its intramitochondrial OXPHOS defects. Displayed here are three representative cells from the simulated population (Fig. 3), each displaying unique characteristics – due to the stochastic modeling techniques used to emulate a real‐world degree of expected randomness. Mitochondrial phenotyping (Fig. 3, row A), referred to hereafter as mito‐phenotyping, allowed us to visualize the totality of the cells’ mitochondrial stress states over time: healthy, fully functioning (green); slightly stressed, unable to greatly activate stress response mechanisms (yellow); significantly stressed, fully capable of stress response activation (orange); and severely damaged, little to no proper respiratory function (red). Some cells saw a steady functional decline with respect to this mito‐phenotyping (Fig. 3, cell 1), whereas others saw modest recovery toward late stages in life (Fig. 3, cells 2 and 3). These stress states correspond well with the levels of mtROS seen in each modeled cell (Fig. 3, row B). Of these representative cells, the third (cell 3) experienced the highest level of oxidative stressors early on, but also experienced the highest level of recovery. This corresponds with the hypothesis that superoxide or other free radical species may not be inherently damaging and may actually provide a signal that promotes longevity (Yang & Hekimi, 2010). Single‐cell mtDNA and significantly damaged mtDNA (∆mtDNA) copy numbers were also assessed in the simulation (Fig. 3, row C), displaying the age‐dependent accumulation of heteroplasmic mtDNA. As expected, the cells that accumulated higher copy numbers of ∆mtDNA faster – especially when far exceeding unperturbed mtDNA copy numbers – experienced the greatest deal of mitochondrial stress.
Figure 3
Stochastic single‐cell mitochondrial health data from three representative cells in the model. (Row A) Mitochondrial stress‐state phenotyping was performed to view the accumulation of stressed or damaged mitochondria over time. Different states of stress are based on metrics of mitochondrial dysfunction, including low respiratory capacity, oxidative burden and poor proteostasis. Some cells saw a steady decline in mitochondrial function (represented by cell 1), whereas others were able to successfully recover significant portions of their mitochondrial populations (represented by cells 2 and 3). (Row B) Single‐cell mitochondrial reactive oxygen species content was captured, which inversely correlated with the corresponding phenotypic trends in mitochondrial health. (Row C) Single‐cell mtDNA and damaged mtDNA (∆mtDNA) copies were analyzed, where high mutation and damage accumulation corresponded with highly dysfunctional phenotypes.
Stochastic single‐cell mitochondrial health data from three representative cells in the model. (Row A) Mitochondrial stress‐state phenotyping was performed to view the accumulation of stressed or damaged mitochondria over time. Different states of stress are based on metrics of mitochondrial dysfunction, including low respiratory capacity, oxidative burden and poor proteostasis. Some cells saw a steady decline in mitochondrial function (represented by cell 1), whereas others were able to successfully recover significant portions of their mitochondrial populations (represented by cells 2 and 3). (Row B) Single‐cell mitochondrial reactive oxygen species content was captured, which inversely correlated with the corresponding phenotypic trends in mitochondrial health. (Row C) Single‐cell mtDNA and damaged mtDNA (∆mtDNA) copies were analyzed, where high mutation and damage accumulation corresponded with highly dysfunctional phenotypes.Mitochondrial dynamics, including biogenesis and selective mitophagy, were simulated, and organelle counts were tracked for an entire population of cells (Fig. 4A). Natural aging (control) allowed for a modest increase in mitochondrial content until a midlife stage, and counts significantly declined until the end of life. This is consistent with previously published trends seen in C. elegans (Palikaras et al., 2015), concerning both general cellular activity as well as neuron‐specific mitochondrial tracking. In the simulated cell population, mtDNA and ∆mtDNA content were tracked and presented as a deleterious heteroplasmic mtDNA percentage (Fig. 4B). As with other makers of age‐related damage, mtDNA copies experienced steady and significant damage with normal aging (control), and the damage percentage saw a slight, yet erratic, decline in late stages of life due to natural defense mechanisms. Oxidative stress levels were measured in silico as well (Fig. 5A), and closely matched spontaneous increases seen previously in C. elegans (Gruber et al., 2011). Experimental and simulation values were both normalized to the respective oxidative stress levels immediately preceding the simulated age‐compromised state (day 7).
Figure 4
Model‐generated mitochondrial counts and heteroplasmic mtDNA content in normal and pharmacologically altered aging. (A) Mitochondrial counts were assessed in our control simulation and also in the same treatment groups as Fig. 2(B), displaying results that give rise to changes in aging mitochondrial dynamics, that is, mitophagy and mitochondrial recycling. (B) Percent of mtDNA damage was calculated in each simulation experiment as an important metric of age‐related mitochondrial dysfunction. Different perturbation schemes modulated the accumulation of mtDNA modifications, which when reduced has been implicated as a relevant intervention in combatting age‐related disease.
Figure 5
Simulation analysis of normal and pharmacologically modified oxidative burden in aging cells. (A) The simulation was able to reproduce age‐related increases in oxidative species as compared to Caenorhabditis elegans data from Gruber and colleagues (Gruber et al., 2011) (ns
P > 0.05). Increases within simulation or experimental data were normalized to their respective levels seen at the time point immediately preceding a fully aged state determined by the model (~day 7). (B) Average oxidative stressor levels, superoxide and peroxide, were determined in a variety of experiments (same treatments as Fig. 2B) for the population of cells simulated over the timeframe of interest. (C) Single‐cell reactive oxygen species (ROS) data were model‐generated for each individual cell in natural aging, in rapamycin‐exposed cells (top panel, overlaid with control), and in pterostilbene‐exposed cells (bottom panel, overlaid with control). These data signify probabilistic, rather than deterministic, mitochondrial activities within each cell giving rise to the natural stochasticity that determines composite ROS values for aging tissues. (D) Simulation time required for cells to switch to the age‐compromised state, characterized by a 10‐fold increase in ROS (100 nm, the approximate level of oxidative stress required to elicit an aged phenotype as determined by the model).
Model‐generated mitochondrial counts and heteroplasmic mtDNA content in normal and pharmacologically altered aging. (A) Mitochondrial counts were assessed in our control simulation and also in the same treatment groups as Fig. 2(B), displaying results that give rise to changes in aging mitochondrial dynamics, that is, mitophagy and mitochondrial recycling. (B) Percent of mtDNA damage was calculated in each simulation experiment as an important metric of age‐related mitochondrial dysfunction. Different perturbation schemes modulated the accumulation of mtDNA modifications, which when reduced has been implicated as a relevant intervention in combatting age‐related disease.Simulation analysis of normal and pharmacologically modified oxidative burden in aging cells. (A) The simulation was able to reproduce age‐related increases in oxidative species as compared to Caenorhabditis elegans data from Gruber and colleagues (Gruber et al., 2011) (ns
P > 0.05). Increases within simulation or experimental data were normalized to their respective levels seen at the time point immediately preceding a fully aged state determined by the model (~day 7). (B) Average oxidative stressor levels, superoxide and peroxide, were determined in a variety of experiments (same treatments as Fig. 2B) for the population of cells simulated over the timeframe of interest. (C) Single‐cell reactive oxygen species (ROS) data were model‐generated for each individual cell in natural aging, in rapamycin‐exposed cells (top panel, overlaid with control), and in pterostilbene‐exposed cells (bottom panel, overlaid with control). These data signify probabilistic, rather than deterministic, mitochondrial activities within each cell giving rise to the natural stochasticity that determines composite ROS values for aging tissues. (D) Simulation time required for cells to switch to the age‐compromised state, characterized by a 10‐fold increase in ROS (100 nm, the approximate level of oxidative stress required to elicit an aged phenotype as determined by the model).While the network motifs employed in our simulation allow us to reproduce the levels of certain age‐dependent respiratory function markers, a sensitivity analysis was also conducted to determine which model functions and constants provide the strongest control over the system. The results of this analysis are tabulated in Table S4 (Supporting Information), where ROS outputs and macromolecule damage levels were sensitively controlled by many different parameters at various ages. Perhaps most notably, mitophagy activity and mitochondrial content at a late age time point were deemed to be the most sensitively controlled by many parameters of the model.
Endpoint changes after control of selective mitophagy
To perturb the computational model, we determined mathematical methods for introducing rapamycin or bafilomycin as regulators of mitophagy (Box S7). Such methods included the estimated dose–response curve for autophagy activation/inhibition as well as the culture pharmacokinetics for determining the presence of each agent. Rapamycin is a well‐known inhibitor of the mechanistic target of rapamycin (mTOR) complex (Robida‐Stubbs et al., 2012), which ultimately allows for increased autophagic activity (Fig. 1; see Rapa). Bafilomycin, on the other hand, inhibits the formation of autophagosomes and therefore inhibits general autophagy and selective mitophagy (Mauro‐Lizcano et al., 2015) (Fig. 1; see Baf). In our simulation, constant low‐level dosing of each of these compounds (15 nm rapamycin or 10 nm bafilomycin, refreshed every 2500 min) was used in these comparative perturbations. As expected, rapamycin (pink line) curbed the decline of ATP production in aging cells within the simulation experiments, whereas bafilomycin (red line) exacerbated this specific decline in energy production (Fig. 2D). Demonstrating that our mathematical perturbations were successful in emulating the function of pharmacological mitophagy modulators, rapamycin and bafilomycin elicited drastic decreases and increases in mitochondrial count compared to the control, respectively (Fig. 4A). In addition, accumulation of deleterious heteroplasmic mtDNA was initiated sooner by bafilomycin exposure and was stunted by exposure to rapamycin (Fig. 4B). Rapamycin was used previously to investigate this exact effect, where it was shown to attenuate the accumulation of mtDNA harboring a specific pathogenic mutation (Dai et al., 2014). As a result of harboring defective mitochondria, simulated mtROS levels were perturbed by these mitophagy modulators as well, where rapamycin‐exposed cells saw less oxidative stress with age and bafilomycin‐exposed cells saw much more (Fig. 5B).
Direct and indirect modulation of age‐dependent oxidative stress levels
To target alternative pathways involved in our in silico cellular mechanism, we chose two particular agents known to modulate mitochondrial processes associated with age‐dependent oxidative damage: paraquat and pterostilbene (Box S7). Paraquat is a well‐established potent ETC uncoupling agent (Park et al., 2009) that causes profound increases in oxidative stress (Fig. 1; see PQ). Pterostilbene is best known as a constituent of certain berries and red wine and as a relative of resveratrol, a more commonly known stilbenoid compound. In contrast to paraquat, exposure to pterostilbene or synthetic relatives has shown to indirectly decrease oxidative stress in C. elegans, in part by contributing to the activation of DAF‐16 and SKN‐1 (Fischer et al., 2017) (Fig. 1; see PT). In our simulation, constant dosing of 100 μm pterostilbene and 5 or 100 μm paraquat was used in these comparative perturbations. Interestingly, ATP content was considerably reduced by high‐dose paraquat but slightly improved by low‐dose paraquat and pterostilbene treatments (Fig. 2D). Compared to the control, low‐dose (light green line) and high‐dose (dark green line) paraquat caused increases and decreases in mitochondrial counts, respectively (Fig. 4A), and only high‐dose paraquat enabled a greater accumulation of ∆mtDNA (Fig. 4B). A similar mtROS‐dependent effect has been shown experimentally for mtDNA double strand breaks causing accelerated aging in mice (Pinto et al., 2017). Virtual pterostilbene exposure (blue line) elicited marginally less mitochondrial turnover toward late age (Fig. 4A). This finding is surprising as stilbene compounds have been suggested as agents that promote autophagy (Poulose, 2015), but perhaps not with selective and nonselective mitophagy. Pterostilbene was the only compound that prolonged the accumulation of ∆mtDNA even though it eventually reached the same percentage as the control (Fig. 4B). This highlights the interesting aging response phenomena associated with stilbene compounds, especially with those that potently affect intramitochondrial reaction networks.Indicating our mathematics were successful in emulating the toxicological uncoupling effect at the ETC, low‐dose paraquat resulted in very slight increases in oxidative stress, whereas the higher dosing scheme prompted a drastic surge in both superoxide and peroxide production (Fig. 5B). It is important to note that although low‐dose paraquat initially causes increases in mtROS, it also at times caused reductions compared to control at late time points. A similar reduction in mtROS was also observed in our simulation after ablating sod‐2 (MnSOD) at increasing levels (Fig. S3A,B). Consistent with previously published nematode data (Fischer et al., 2017), pterostilbene administration in our analysis allowed for around a 20–25% reduction (slowly reversible) in oxidative stress at the maximal response time points in the model after reaching fully aged states (Fig. 5B). As pterostilbene and rapamycin showed the most promising results for slowing the damaging effects of aging mitochondria, we analyzed their oxidative stress modulation at the single‐cell level. Our computational model allowed us to visualize mtROS levels over time overlaid with control data for a population of cells (n = 65; 500 time points), demonstrating both the highly stochastic nature of the model and the protective effects of rapamycin (Fig. 5C, top panel) and pterostilbene (Fig. 5C, bottom panel). To distill this information, we determined that 100 nm combined superoxide and peroxide allowed for a deleteriously aged cellular phenotype and assessed how many cells crossed this threshold at various time points for natural aging (control), rapamycin, and pterostilbene (Fig. 5D). Pterostilbene and rapamycin greatly extended the time required for the majority of cells to cross this threshold; however, rapamycin further reduced the number of total cells that experienced this aged phenotype.
Cell death predictions and implications for age‐related neurodegeneration
Given that aging and senescence are implicated in various cognitive deficits and neurodegenerative diseases, we used our computational methods to ultimately simulate an age‐compromised cell state and subsequent probabilistic death for postmitotic energetically demanding cells (Fig. 6A). The rate of spontaneous degeneration simulated here corresponds well with wide speculations made about the slow loss of neuronal mass that accompanies old age in mammals (Peters, 2006). This degenerative response has been more complex to quantitate in nematodes, as the neuronal network appears to be conserved with age (Herndon et al., 2002) yet vacuolization and cellular damage certainly occur (Hall et al., 1997). Cells within the model began to enter the compromised state around 10 000 min, shortly after cells began crossing the model‐determined mtROS threshold (10‐fold increase) as mentioned in the previous section and shown in Fig. 5D. Viable cell and cell survival curves, associated with age‐compromised cell states and degenerative aging, were generated for a battery of in silico mechanistic perturbations, including the pharmacological treatments of interest as well as reductions in sod‐2, daf‐16 and skn‐1 expressions (Fig. 6B,C). Pterostilbene exposure (blue lines) rapamycin exposure (pink lines), low‐dose paraquat exposure (light greens) and 90% sod‐2 ablation (yellow lines) all delayed immersion into compromised states and extended cellular longevity, with rapamycin and pterostilbene eliciting the strongest effects. The remaining treatment groups, bafilomycin (red lines) high‐dose paraquat (dark green lines), 90% daf‐16 ablation (orange lines) and skn‐1 ablation (purple lines), all resulted in rapid aging and severely decreased survival rates. While sod‐2 ablation resulted in a marginally beneficial response, our simulation results indicate that its expression must be fully reduced to see any increases in longevity‐promoting effects (Fig. S3C,D), due to the stress responses that the increased endogenous mtROS activate. This aging delay brought on by the mathematical model substantiates previous studies that have linked increases in oxidative species to extended lifespans (Yang & Hekimi, 2010; Gruber et al., 2011); however, the timing and duration of genetically or pharmacologically induced mtROS must play a critical role in regulating these mechanisms as well.
Figure 6
Age‐dependent total cellular damage and degeneration analysis. (A) Natural aging, presumably as a result of faulty mitochondrial dynamics, forced healthy cells (blue) into a compromised state (red) in our simulation, where they were required to overcome mitochondrial defects in order to recover. If recovery was insufficient, they died off (gray). (B) The dynamics of natural age‐compromised cell accumulation (control) was compared to those virtually altered by pharmacological (rapamycin, bafilomycin, paraquat, or pterostilbene exposure) and genetic (daf‐16, skn‐1, or sod‐1 ablation) simulation schemes. (C) Natural cell survival rates were compared to the same perturbation schemes of interest. Many schemes caused cells to age faster in the simulation, resulting in more death early on. Some simulation perturbations, however, were able to slow the rate of aging and natural degeneration, either slightly or robustly.
Age‐dependent total cellular damage and degeneration analysis. (A) Natural aging, presumably as a result of faulty mitochondrial dynamics, forced healthy cells (blue) into a compromised state (red) in our simulation, where they were required to overcome mitochondrial defects in order to recover. If recovery was insufficient, they died off (gray). (B) The dynamics of natural age‐compromised cell accumulation (control) was compared to those virtually altered by pharmacological (rapamycin, bafilomycin, paraquat, or pterostilbene exposure) and genetic (daf‐16, skn‐1, or sod‐1 ablation) simulation schemes. (C) Natural cell survival rates were compared to the same perturbation schemes of interest. Many schemes caused cells to age faster in the simulation, resulting in more death early on. Some simulation perturbations, however, were able to slow the rate of aging and natural degeneration, either slightly or robustly.
Discussion
Biological aging is the primary phenomenon governing organismal fitness and has often been deemed the most important risk factor in debilitating and fatal diseases. Age‐dependent diseases that are degenerative or senescence‐controlled in nature are generally confined to tissues with high energy demands, such as skeletal and cardiac muscle and nervous tissue (Niccoli & Partridge, 2012). These incidences suggest that severe mitochondrial dysfunction and aging are not mutually exclusive processes. The fundamental causalities between the two, however, are considerably complex and challenging to investigate, denoting the ongoing need for innovative and powerful methods in aging research. To provide an additional and systematic means of investigation, we have designed a computational network that integrates many of the sophisticated experiments completed in recent years. By balancing spontaneous free radical damage as well as corresponding mitochondrial stress responses, we have been able to make apt predictions about the aging process in a well‐studied model organism. Several of our large‐dataset predictions have been validated quantitatively (Figs 2A–C and 5A) or qualitatively, while several have yet to be experimentally examined, leaving well‐designed hypotheses for future work.As part of our modeling study, we sought to understand how crucial the UPRmt and mitophagy are in balancing the oxidative stress and macromolecule damage that accompany normal, healthy aging. It was revealed in our experiments and global sensitivity analysis that mitochondrial turnover and quality control levels were the most important processes in either softening or exacerbating the deleterious effects of mitochondrial dysfunction in aging. This is substantiated by previous experiments carried out in C. elegans, which suggest the UPRmt is not a potent regulator of longevity pathways (Bennett et al., 2014), whereas mitophagy likely is (Palikaras & Tavernarakis, 2012). The UPRmt, although not apparently important in regulating the lifespan of a full organism, may play a critical role in the cellular aging mechanisms that regulate tissue‐specific healthspans. This is especially true for sensitive tissues with high mitochondrial counts, as they have a direr need to quickly regulate their antioxidant defenses and mitochondrial protein environments. Adding to this complexity, activation of this response must be performed carefully, and likely on a low‐frequency basis, as the UPRmt has been implicated as a mechanism that can protect aberrant mitochondrial contents (Lin et al., 2016). In particular, overactivation of this response has been linked to a higher persistence of mtDNA heteroplasmy. The mechanisms by which this occurs are poorly understood, although they are not entirely dependent upon mitophagy. However, mitophagy may certainly play a small role in the UPRmt's ability to maintain defective mitochondria, as TIMM‐23 expression is upregulated by the UPRmt and is responsible for the import and degradation of pro‐mitophagy proteins such as PINK‐1 (Menzies et al., 2015). Therefore, an overexpression of TIMM‐23 may limit, for a short duration of time, the amount of mitophagy activity. In contrast to this theory, it has been shown that the complete absence of TIMM‐23 isoforms constitutively induces the UPRmt and leads to decreases in lifespan (Bennett et al., 2014). These observations exemplify the physiological need for an incredibly tight regulation of TIMM‐23‐dependent transport processes and mitophagic activities that may be programmed to vary with age in an attempt to maximize mitochondrial healthspans.In addition to gaining mechanistic insights, we used our multimethod simulation to predict the cellular effects brought on by different pharmacological agents that have been widely studied as modulators of aging, especially in neuronal tissue. Most agents that have been discovered as longevity‐promoters have also been known to promote mitochondrial health. Rapamycin exposure has led to stark increases in stress resistance to age‐dependent damage in a wide variety of organisms (Robida‐Stubbs et al., 2012; Kolosova et al., 2013; Martínez‐Cisuelo et al., 2016), presumably due to its regulatory role in metabolic processes and nonselective autophagy. In our simulation experiments, we applied it as a mitophagy inducer and observed remarkable decreases in heteroplasmic mtDNA content and increases in antioxidant capacity. Both of these rapamycin‐induced effects have been observed experimentally (Robida‐Stubbs et al., 2012; Dai et al., 2014). Previous experiments and our simulation work draw attention to rapamycin as not only an agent that can extend the lifespan of an organism, but as a compound that does so by preserving the quality of mitochondria. Plant‐derived polyphenols, such as resveratrol and pterostilbene, have also been studied for their potential ability to stunt the aging process through antioxidant activities and mitochondrial pathways. In C. elegans, resveratrol has been shown to alleviate oxidative stress and resulting mitochondrial damage associated with respiratory chain deficiencies, resulting in extended lifespan (McCormack et al., 2015). Although a significant portion of the literature has documented the longevity‐promoting effects of resveratrol, much of the recent focus has fallen on pterostilbene and synthetic derivatives, as they have been observed as more potent compounds capable of modulating cellular processes in aging and age‐related neurodegeneration (Chang et al., 2012; Fischer et al., 2017), in part through the DAF‐16 and SKN‐1 axes. For this reason, we chose pterostilbene as the virtual stilbene compound to be used in our simulation work. Based on dose–response data that allowed us to calculate its mtROS remediation (Fischer et al., 2017), pterostilbene prolonged mitochondrial damage accumulation and age‐dependent cellular degeneration in our simulations, albeit to a lesser extent than rapamycin. Notably, pterostilbene acts by increasing the activity of NAD+‐dependent deacetylases known as sirtuins (Imai & Guarente, 2014), which promote well‐balanced oxidative metabolism within mitochondria, and particular isoforms are involved in activating the UPRmt (Mouchiroud et al., 2013; Papa & Germain, 2014). If the UPRmt and mild antioxidant defenses are not as powerful anti‐aging contributors as mitophagy and mitochondrial biogenesis, this explains the more favorable simulation results returned for rapamycin. Pterostilbene, however, has been known to induce autophagy on some level (Poulose, 2015), and NAD+‐dependent sirtuin activities are important in regulating not only bioenergetic functions and antioxidant capacity but mitochondrial dynamics as well (Fang et al., 2014); therefore, it must be investigated whether this compound can effectively stimulate the process of selective mitophagy in relevant cell types to promote significant increases in mitochondrial quality.Computational modeling has recently become a more commonplace technique in gerontological research, with many different types of developed models surfacing over the past decade (Mooney et al., 2016). Such models include purely deterministic analyses of oxidative metabolism (Cloutier & Wellstead, 2012), well‐developed Boolean approaches for understanding molecular aging networks (Verlingue et al., 2016), discrete‐event modeling of mtDNA dynamics (Tam et al., 2015), and high‐precision statistical modeling of lifespan determinants (Stroustrup et al., 2016).Here we have contributed a new multimethod computational modeling technique for studying the cellular mechanisms of aging as they relate to mitochondrial function and dysfunction. We have built the groundwork for a comprehensive computational model that can reproduce levels of mitochondrial and cellular biomarkers implicated in aging, with respect to C. elegans. In particular, our model has highlighted the potent effects of (i) mitophagy induction or inhibition and (ii) the critical stress response genes, such as daf‐16 and skn‐1, required to maintain healthy aging and to further promote longevity through oxidative mechanisms. After further mechanism integration and experimental interrogation, this computationally intensive tool may be able to accurately predict aging phenotypes and neurodegenerative disease markers – first in nematodes and eventually in larger, more complex organisms. In addition, future in silico interrogations will provide a powerful, quick, high‐throughput, and cost‐effective means by which to test experimental drugs and dietary supplements that may very well slow the deleterious effects of aging and the pathogenesis of age‐related diseases.
Experimental procedures
Hierarchical cell simulation design and agent‐based modeling
To simulate intramitochondrial system dynamics and global cellular reactions, we formulated our model using AnyLogic® multimethod simulation software (The AnyLogic Company, Chicago, IL, USA), which allowed us to develop a hierarchical agent‐based simulation scheme. This allowed us to simulate a population of cell agents, with each individual cell agent containing its own population of mitochondrion agents (Fig. 1B). Each agent contained discrete‐event statements and system‐dynamics reaction networks, both of which were programmed to deal with natural biological stochasticity. As a critical agent‐based element employed in our model, cells harboring a high percentage of faulty mitochondria were forced into a compromised state via a discrete event. These types of events can be activated once a particular condition is met, and in this case, the event was triggered once enough mitochondria were severely damaged and defective. As this percentage trigger is presumably different for each cell, we incorporated a stochastic transition statement that allowed each cell to pull from a triangular probability:The range is denoted by the outer bounds and the most probable value is denoted by the middle value of 65%. Similar agent‐based principles were utilized for mitochondrial stress‐state transitions and are fully outlined in the Supporting Information.
Deterministic modeling components
Many biological events have been proposed as crucial elements in regulating cellular and organismal lifespan. We manually selected and organized several such elements from the literature and implemented them in complement to our agent‐based work as a deterministic modeling framework, that is, an intricate web of molecule‐dependent ODEs. Such elements included (i) mitochondrial reaction networks that govern oxidative metabolism, proteostasis, and genomic alterations and (ii) global cellular reaction networks pertaining to ATFS‐1 movement in the cell, protein synthesis, and mitochondrial import. The majority of these curated reactions are detailed in Fig. 1(A), and all of the equations and corresponding parameters used are organized and tabulated in the Supporting Information.
Sensitivity analysis
To determine the quantitative significance of certain parameters and functions within the system, a similar global sensitivity strategy was used that has been described previously (Tam et al., 2015). Briefly, each parameter was individually reduced by 5%, and the resulting model outputs, referred to in the text as response variables, were assessed. This was done for all static parameters within the model, and the changes in several response variables (e.g., ROS output) were measured at particular time points determined for young age, midlife, and old age. Sensitivity coefficients for each scenario were calculated:where SC represents the normalized sensitivity coefficient, O
is the model output value, P
is the value of the parameter of interest, and ∂ represents the partial derivative of either the parameter value or model output. When |SC| ≥ 1.0000, that is, when the proportional change in the response variable is greater than the proportional change in the parameter, the parameter is deemed to have significant sensitive control over the respective output at the specified age.
Statistical analysis
Statistical significance was determined by using GraphPad Prism 7.0 software, and P values were calculated by a one‐way analysis of variance (ANOVA). Significance was considered to be a P value of 0.05.
Author contributions
WHH contributed the software packages and analytical tools. TEH and WHH conceived the theories and hypotheses prior to in silico experimentation. TEH, WHH, and LW developed the methodologies and simulation experiments. TEH performed the research experiments and analyzed the data. WHH, LW, and KJB examined the data and provided significant feedback. TEH, WHH, KJB, and LW contributed significantly to the preparation of this manuscript.
Funding
This work was supported by the Center for Environmental Medicine at Colorado State University.
Conflict of Interest
The authors declare no conflict of interest.Fig. S1 Schematics of mitochondrion‐level modeling dynamics.Fig. S2 Schematics of cell‐level modeling dynamics.Fig. S3 MnSOD simulation experiments for varying gene expression levelsTable S1 Cellular and anatomical parameters of interest for C. elegans.Table S2 Parameters of interest for the proposed intramitochondrial system.Table S3 Parameters of interest for the proposed intracellular system.Table S4 Normalized sensitivity coefficients against respective response variables.Box S1 Equations pertaining to the estimation of nematode‐specific cellular parameters.Box S2 Equations and event statements pertaining to mitochondrion‐level kinetics.Box S3 Conditional and rate‐dependent statements governing the rule‐based categorization of mitochondrial stress, via the agent‐based paradigm.Box S4 Equations pertaining to cell‐level kinetics.Box S5 Conditional and rate‐dependent statements governing the rule‐based categorization of cell integrity, via the agent‐based paradigm.Box S6 Equations used to capture tissue concentrations of endpoints of interest.Box S7 Functions used to define virtual pharmacological perturbations within the model.Click here for additional data file.
Authors: Nataliya G Kolosova; Anton O Vitovtov; Natalia A Muraleva; Andrey E Akulov; Natalia A Stefanova; Mikhail V Blagosklonny Journal: Aging (Albany NY) Date: 2013-06 Impact factor: 5.682
Authors: Nicholas Stroustrup; Winston E Anthony; Zachary M Nash; Vivek Gowda; Adam Gomez; Isaac F López-Moyado; Javier Apfeld; Walter Fontana Journal: Nature Date: 2016-01-27 Impact factor: 49.962
Authors: Natalie Moroz; Juan J Carmona; Edward Anderson; Anne C Hart; David A Sinclair; T Keith Blackwell Journal: Aging Cell Date: 2014-09-25 Impact factor: 9.304
Authors: Christopher F Bennett; Helen Vander Wende; Marissa Simko; Shannon Klum; Sarah Barfield; Haeri Choi; Victor V Pineda; Matt Kaeberlein Journal: Nat Commun Date: 2014-03-24 Impact factor: 14.919
Authors: Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong Journal: Autophagy Date: 2021-02-08 Impact factor: 13.391
Authors: Samprikta Manna; Camino S M Ruano; Jana-Charlotte Hegenbarth; Daniel Vaiman; Shailendra Gupta; Fergus P McCarthy; Céline Méhats; Cathal McCarthy; Clara Apicella; Julia Scheel Journal: Antioxidants (Basel) Date: 2022-03-18